Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
139.70
-3.20 (-2.24%)
At close: May 19, 2026, 4:00 PM EDT
139.70
0.00 (0.00%)
After-hours: May 19, 2026, 5:30 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $5.5 billion as of May 19, 2026. Its market cap has increased by 171.70% in one year.
Market Cap
5.50B
Enterprise Value
5.02B
1-Year Change
171.70%
Ranking
Category
Stock Price
$139.70
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $5.50B, an increase of 3,701.42%. That is a compound annual growth rate of 145.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 5.62B | -6.32% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 5.98B |
| Apogee Therapeutics | 5.87B |
| Mirum Pharmaceuticals | 5.83B |
| PTC Therapeutics | 5.83B |
| Spyre Therapeutics | 5.79B |
| Scholar Rock Holding | 5.70B |
| TG Therapeutics | 5.59B |
| CG Oncology | 5.58B |